Repligen Corp
Veridion Score
Composite trend over time
Why is RGEN moving today?
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for RGEN.
RGEN insider activity
Repligen Corp
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for RGEN.
RGEN contract awards, year to date.
Public federal awards linked to this ticker.
RGEN lobbying filings, year to date.
Registered lobbying filings matched to Repligen Corp.